ERBB2 and breast carcinoma: This study relied on only two cell lines, MCF7 (luminal) and MB231 (TNBC, basal-like), and did not evaluate the effects of LCFAs on other breast cancer subtypes (e.g., HER2-positive, luminal B, other TNBC lines).